Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00167180
Title Post Transplant Donor Lymphocyte Infusion
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota

hematologic cancer


Cyclophosphamide + Fludarabine

Age Groups: child | adult
Covered Countries USA

No variant requirements are available.